News Medical on MSN6d
Key information to consider before getting breast implantsShould I get breast implants? Should they be saline or silicone? Which style? How much monitoring is needed after surgery?
The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...
Luckily for me, by 2016, when I opted for breast reconstruction ... “gummy bear” implants because they were the most “natural-looking”; however, by June 2023, the FDA would associate ...
In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan ...
HealthDay on MSN3d
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast CancerThe U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult pat ...
Breast augmentation is a popular cosmetic procedure ... The recent updates from the U.S. Food and Drug Administration (FDA) have also emphasized the importance of MRI screening for women with ...
HER2-low or HER2-ultralow metastatic breast cancer following endocrine therapy.” Trastuzumab deruxtecan is a HER2-directed antibody-drug conjugate (ADC) developed using Daiichi Sankyo's ...
The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer.The new indication applies to use of ...
T-DXd, an antibody-drug conjugate now approved for multiple tumor types, gained approval in 2022 for unresectable or metastatic HER2-low breast cancer -- defined by an FDA-approved test as IHC 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback